The UK government plans to cut the number of health-related agency bodies from 18 to between just eight and ten, as part of an exercise to streamline the organisations and deliver savings of over £180m (US$279 million) by 2014-15 1 ,2 . Its move ...
The Australian Therapeutic Goods Administration has been restructured in an effort to better support the delivery of appropriate, consistent, effective and efficient regulation 1 ,2 . This is the first comprehensive review of the agency that has ...
Dr Richard Barker, the director general of the Association of the British Pharmaceutical Industry , says the National Institute for Health and Clinical Excellence should not set drug prices as part of the coalition government's planned value-based ...
Germany's health technology appraisal institute, IQWiG, has elected Professor Jürgen Windeler as its new director. The chief physician and deputy managing director of the MDS (Essen) ? the medical advisory board for statutory health insurers and ...
Civil servants at the Department of Health in London are quietly working on what may turn out to be a whole new pricing system for medicines in the UK following the publication of the coalition government's white paper on the National Health ...
The Department of Health in England and Wales has said it will look at the price rises of a "small number" of generic medicines 1 . "We are aware that the prices of a small number of medicines have risen in recent times and we are reviewing what ...
The European Medicines Agency expects to adopt in October a new approach on how it manages the conflicts of interests of external scientific experts who advise it on the assessment of new drugs and other innovative medicinal products. Vibha Sharma ...
The Council of Europe?sparliamentary assembly has endorsed claims by its health committee that the World Health Organization overplayed the seriousness of the flu pandemic, leading to unjustified scares about the risks faced by the public and the ...
Neena Brizmohun charts some of the more high-profile regulatory developments in 2009 and considers their implications for the year ahead. There is nothing wrong with change, if it is in the right direction ? Winston Churchill, former British Prime ...
The US Senate's 60-39 vote allowing debate to begin on a healthcare reform bill was heralded by Democratic leaders as a milestone in overhauling the nation's delivery of medical services 1 -3 . Yet, the chamber's leadership has a long way to go in ...
